Related references
Note: Only part of the references are listed.Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis A Randomized Clinical Trial
Richard K. Burt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis
Gianluigi Mancardi et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis
Gianluigi Mancardi et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms
Tobias Alexander et al.
JOURNAL OF AUTOIMMUNITY (2018)
Multiple Sclerosis: Mechanisms and Immunotherapy
Clare Baecher-Allan et al.
NEURON (2018)
Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases - a guide for the generalist
John A. Snowden et al.
CLINICAL MEDICINE (2018)
Mesenchymal stromal cells and autoimmunity
Vito Pistoia et al.
INTERNATIONAL IMMUNOLOGY (2017)
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
Paolo A. Muraro et al.
NATURE REVIEWS NEUROLOGY (2017)
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
Bonaventura Casanova et al.
NEUROLOGICAL SCIENCES (2017)
Alemtuzumab CARE-MS I 5-year follow-up Durable efficacy in the absence of continuous MS therapy
Eva Havrdova et al.
NEUROLOGY (2017)
Alemtuzumab CARE-MS II 5-year follow-up
Alasdair J. Coles et al.
NEUROLOGY (2017)
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
Richard A. Nash et al.
NEUROLOGY (2017)
Autologous hematopoietic stem cell transplantation in multiple sclerosis A meta-analysis
Maria Pia Sormani et al.
NEUROLOGY (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
Paolo A. Muraro et al.
JAMA NEUROLOGY (2017)
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases
John A. Snowden et al.
BLOOD ADVANCES (2017)
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial
Harold L. Atkins et al.
LANCET (2016)
A study of patients with aggressive multiple sclerosis at disease onset
Ulrike W. Kaunzner et al.
Neuropsychiatric Disease and Treatment (2016)
Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives
Jury L. Shevchenko et al.
ANNALS OF HEMATOLOGY (2015)
Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis
Richard K. Burt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study
Daniela Curro et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Aggressive multiple sclerosis: proposed definition and treatment algorithm
Carolina A. Rush et al.
NATURE REVIEWS NEUROLOGY (2015)
Autologous hematopoietic stem cell transplantation in multiple sclerosis A phase II trial
Giovanni L. Mancardi et al.
NEUROLOGY (2015)
High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS) A 3-Year Interim Report
Richard A. Nash et al.
JAMA NEUROLOGY (2015)
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study
Daniela Curro et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)
E. Snarski et al.
BONE MARROW TRANSPLANTATION (2015)
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
Orla Tuohy et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
Joachim Burman et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Characterising aggressive multiple sclerosis
Suresh Menon et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Transplantation for Autoimmune Diseases in North and South America: A Report of the Center for International Blood and Marrow Transplant Research
Marcelo C. Pasquini et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results
J. D. Bowen et al.
BONE MARROW TRANSPLANTATION (2012)
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation
J. A. Snowden et al.
BONE MARROW TRANSPLANTATION (2012)
Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis
Jury L. Shevchenko et al.
EXPERIMENTAL HEMATOLOGY (2012)
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
G. L. Mancardi et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper
R. Saccardi et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Long-term efficacy of autologous haematopoietic stem cell transplantation in multiple sclerosis at a single institution in China
Bing Chen et al.
NEUROLOGICAL SCIENCES (2012)
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial
A. J. Coles et al.
NEUROLOGY (2012)
Interferon Beta-1b for the Treatment of Primary Progressive Multiple Sclerosis Five-Year Clinical Trial Follow-up
Carmen Tur et al.
ARCHIVES OF NEUROLOGY (2011)
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
Gavin Giovannoni et al.
LANCET NEUROLOGY (2011)
Long-term results of stem cell transplantation for MS A single-center experience
A. Fassas et al.
NEUROLOGY (2011)
The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments
Peter Connick et al.
TRIALS (2011)
Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG
N. Hamerschlak et al.
BONE MARROW TRANSPLANTATION (2010)
The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
Antonio Scalfari et al.
BRAIN (2010)
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases
Dominique Farge et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience
Eva Krasulova et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
Kathleen Hawker et al.
ANNALS OF NEUROLOGY (2009)
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
Eva Havrdova et al.
LANCET NEUROLOGY (2009)
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis a phase I/II study. (vol 8, pg 244, 2009)
R. K. Burt et al.
LANCET NEUROLOGY (2009)
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
Richard K. Burt et al.
LANCET NEUROLOGY (2009)
Transplantation of Bone Marrow Transduced to Express Self-Antigen Establishes Deletional Tolerance and Permanently Remits Autoimmune Disease
James Chan et al.
JOURNAL OF IMMUNOLOGY (2008)
Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis
Alasdair J. Coles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases - The evolution from myeloablative to lymphoablative transplant regimens
Richard K. Burt et al.
ARTHRITIS AND RHEUMATISM (2006)
Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning
Su Ming Yvonne Loh et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natural history of multiple sclerosis: a unifying concept
C Confavreux et al.
BRAIN (2006)
Hematopoietic stem cell transplantation for multiple sclerosis - A retrospective multicenter study
T Kozak et al.
JOURNAL OF NEUROLOGY (2002)
Relapses and progression of disability in multiple sclerosis.
C Confavreux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
